11/7/2023 0 Comments Endo pharmaceuticals![]() "It's overdose deaths, it's people losing their jobs, losing their dignity. It has really ripped at the fabric of our community," said Barry Staubus, district attorney in Sullivan County Tennessee. They claim Endo's opioid medication Opana ER was marketed aggressively in the state without proper safeguards, contributing to high rates of addiction and death. Stranch's legal team filed a series of complaints with the court about Endo's conduct in the case, which led to the judge's order.Ī controversial opioid, a devastating epidemicĪt issue is a lawsuit filed in 2017 by county prosecutors and other local government officials in eastern Tennessee. " lawyers crossed the line and worked with the company to subvert the court's orders and then made false statements to the court about it," he said. In a statement emailed to NPR the company said it will appeal the judgement.īut Gerard Stranch, one of the attorneys suing the drugmaker on behalf of local governments in Tennessee, said Endo and its lawyers "conspired to hide the truth" over a period of years as the fact-finding phase of the trial proceeded. Moody in a judgment issued on April 6.Įndo denies wrongdoing. "It appears to the court that Endo and its attorneys, after delaying trial, have resorted to trying to improperly corrupt the record," wrote Chancellor E.G. The judge presiding over the civil trial also concluded the drugmaker and its attorneys made at least a dozen false statements during the pretrial fact-finding process. Parent penalty totals are adjusted to avoid double-counting. $ 11,000,000A state judge in Tennessee ruled the drug company Endo Pharmaceuticals is liable for harm caused by their opioid drug, Opana ER.Ī state court in Tennessee has punished Endo Pharmaceuticals for improperly withholding a vast trove of documents relating to the sale and marketing of its opioid medication Opana ER. ![]() (*) Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $ 22,500,000 Parent penalty totals are adjusted to avoid double-counting. $ 39,000,000 and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals and Endo Pharmaceuticals Inc.Įndo Health Solutions and Endo PharmaceuticalsĮndo Pharmaceuticals Inc. Parent penalty totals are adjusted to avoid double-counting. $ 173,000,000Įndo Health Solutions Inc. Or Save your search ( Click here for information on download subscriptions) Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.Ĭlick on the company or penalty amount for more information on each case. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. Price-fixing or anti-competitive practices Off-label or unapproved promotion of medical products Ownership Structure: publicly traded (ticker symbol ENDP)ĭrug or medical equipment safety violation Violation Tracker Current Parent Company Summary Current Parent Company Name: Endo International
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |